Colgate-Palmolive (NYSE:CL) is a well-known consumer products company, primarily recognized for its oral care, personal care, home care, and pet nutrition products. The company competes with other giants like Procter & Gamble and Unilever in the consumer goods sector. On April 25, 2025, CL reported impressive quarterly earnings, showcasing its strong market position.
CL reported earnings per share (EPS) of $0.91, surpassing the Zacks Consensus Estimate of $0.86. This marks an improvement from the $0.86 EPS reported in the same quarter last year. The company’s revenue reached approximately $4.91 billion, exceeding the estimated $4.87 billion, highlighting its robust sales performance.
The company’s price-to-earnings (P/E) ratio is around 26.13, indicating that investors are willing to pay $26.13 for every dollar of earnings. This suggests a positive market sentiment towards CL’s future earnings potential. The price-to-sales ratio of 3.73 reflects the market’s valuation of its revenue, while the enterprise value to sales ratio of 4.10 shows how the market values the company’s total worth relative to its sales.
Colgate-Palmolive’s enterprise value to operating cash flow ratio is approximately 20.04, providing insight into its valuation concerning cash generation. The earnings yield of about 3.83% offers a perspective on the return investors can expect. The company’s debt-to-equity ratio of 40.15 indicates a balanced approach to financing its assets, while a current ratio of 0.92 suggests its ability to cover short-term liabilities with short-term assets.
